NantHealth Inc
NASDAQ:NH
Intrinsic Value
NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. [ Read More ]
The intrinsic value of one
NH
stock under the Base Case scenario is
24.7201
USD.
Compared to the current market price of 0.4219 USD,
NantHealth Inc
is
Undervalued by 98%.
NantHealth Inc's market capitalization is 3.3m USD.
NH stock price is 0.4219 USD.
NH stock price (0.4219 USD) is 98% less than its Intrinsic Value (24.7201 USD).
NH. Open DCF Valuation
NH stock price (0.4219 USD) is 98% less than its Relative Value (24.7201 USD). Open Relative Valuation
NH.
NH has positive three-year average ROE (Return on Equity): 10%. The company is efficient at transforming stockholders' equity into net income.
NH's Revenue has grown by 7% over the past 12 months.
NH's ROE (Return on Equity) for the past 12 months is very high and is equal to 30%.
NH has negative Operating Income for the last twelve months.
NH has negative Net Income for the last twelve months.
NH's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -35%.
NH has positive Gross Profit for the last twelve months.
NH's long-term liabilties (411m USD) exceed its long-term assets (157m USD).
NH has negative Free Cash Flow for the last twelve months.
NH has negative three-year average ROIC (Return on Invested Capital): -12%. The company is not efficient at using invested capital to generate operating income.
NH's short-term liabilties (59m USD) exceed its short-term assets (15m USD).
NH has positive Net Debt. This means that the company has more debt (332m USD) than cash and short-term investments (6m USD).
NH's D/E (Debt to Equity) is very low and is equal to -1.36.
NH's Altman Z-Score is very low and is equal to -10.61.
NH doesn't generate enough operating income (-51m USD) to safely cover interest payments on its debt (6m USD).
Fundamental Analysis
NantHealth Inc
Balance Sheet Decomposition
NantHealth Inc
| Current Assets | 12.6m |
| Cash & Short-Term Investments | 1.8m |
| Receivables | 7.7m |
| Other Current Assets | 3.2m |
| Non-Current Assets | 147m |
| PP&E | 16.7m |
| Intangibles | 128.4m |
| Other Non-Current Assets | 1.9m |
| Current Liabilities | 35.6m |
| Accounts Payable | 10.4m |
| Accrued Liabilities | 16.4m |
| Short-Term Debt | 560k |
| Other Current Liabilities | 8.3m |
| Non-Current Liabilities | 349.3m |
| Long-Term Debt | 306.6m |
| Other Non-Current Liabilities | 42.7m |
Earnings Waterfall
NantHealth Inc
|
Revenue
|
67m
USD
|
|
Cost of Revenue
|
-28.8m
USD
|
|
Gross Profit
|
38.2m
USD
|
|
Operating Expenses
|
-89.5m
USD
|
|
Operating Income
|
-51.3m
USD
|
|
Other Expenses
|
-16.5m
USD
|
|
Net Income
|
-67.8m
USD
|
Free Cash Flow Analysis
NantHealth Inc
NH Profitability Score
Profitability Due Diligence
NantHealth Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
NantHealth Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
NH Solvency Score
Solvency Due Diligence
NantHealth Inc's solvency score is 18/100. The higher the solvency score, the more solvent the company is.
Score
NantHealth Inc's solvency score is 18/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NH Price Targets Summary
NantHealth Inc
Ownership
NH Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
NH Price
NantHealth Inc
| Average Annual Return | 66.17% |
| Standard Deviation of Annual Returns | 144.33% |
| Max Drawdown | -100% |
| Market Capitalization | 3.3m USD |
| Shares Outstanding | 7 702 872 |
| Percentage of Shares Shorted | 1.88% |
Company Profile
NantHealth Inc
Country
Industry
Market Cap
Dividend Yield
Description
NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The company is headquartered in Culver City, California and currently employs 326 full-time employees. The company went IPO on 2016-06-02. NantHealth is a provider and payers for software and devices that live at the intersection of precision medicine and value-based care. NantHealth's products include Eviti, NaviNet, and OpenNMS. Eviti is a decision support platform that provides evidence-based clinical decision support. NaviNet is a payer-provider collaboration platform a secure, multi-payer Web portal that lets payers and providers exchange administrative and clinical information in real-time. OpenNMS is an open-source network monitoring solution for enterprise-grade networks. Its solutions include data management, analysis and interpretation solutions, network monitoring, software-as-a-service platforms, and molecular profiling solutions, enabling value-based care and evidence-based clinical practice.
You don't have any saved screeners yet
